Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digoxin with Decitabine in AML and MDS
NCT03113071Phase 2Terminated
- Sponsor
- Fox Chase Cancer Center
- Start
- Jun 2017
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of digoxin in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by Fox Chase Cancer Center. Started Jun 2017; status: terminated.
02
Drugs
digoxin
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT03113071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03113071.